Parkinson’s Disease / 2018 / Article / Tab 3

Research Article

The Effect of Parkinson’s Disease on Patients Undergoing Lumbar Spine Surgery

Table 3

Comorbidities of patients with and without PD.

ComorbiditiesNo PDPD value

Congestive heart failure1.943.61<0.0001
Valvular heart disease2.864.34<0.0001
Pulmonary circulation disease0.510.870.001
Peripheral vascular disease2.433.120.006
Hypertension49.5055.53<0.0001
Paralysis1.652.73<0.0001
Chronic pulmonary disease13.9910.62<0.0001
Diabetes w/o chronic complications14.8814.220.276
Diabetes w/chronic complications1.542.260.000
Hypothyroidism9.5612.99<0.0001
Renal failure1.682.390.001
Liver disease0.760.330.002
Peptic ulcer disease0.020.050.160
Acquired immune deficiency syndrome0.030.050.544
Lymphoma0.230.220.869
Metastatic cancer0.160.160.916
Solid tumor w/o metastasis0.350.76<0.0001
Rheumatoid arthritis2.822.610.438
Coagulopathy1.212.16<0.0001
Obesity10.185.79<0.0001
Weight loss0.380.91<0.0001
Fluid and electrolyte disorders6.158.46<0.0001
Chronic blood loss anemia0.871.010.374
Deficiency anemia6.898.69<0.0001
Alcohol abuse0.920.540.014
Drug abuse0.790.500.041
Psychoses1.692.79<0.0001
Depression10.9412.460.002
Osteoporosis3.957.89<0.0001

PD: Parkinson’s disease.